Logo image of PSB

PS BUSINESS PARKS INC/MD (PSB) Stock Fundamental Analysis

NYSE:PSB - New York Stock Exchange, Inc. - US69360J1079 - REIT - Currency: USD

187.44  +0.06 (+0.03%)

After market: 187.5 +0.06 (+0.03%)

Fundamental Rating

2

Taking everything into account, PSB scores 2 out of 10 in our fundamental rating. PSB was compared to 129 industry peers in the Diversified REITs industry. PSB may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, PSB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PSB was profitable.
PSB Yearly Net Income VS EBIT VS OCF VS FCFPSB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

1.2 Ratios

Industry RankSector Rank
ROA 22.65%
ROE 27.57%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSB Yearly ROA, ROE, ROICPSB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15 20 25

1.3 Margins

Industry RankSector Rank
OM 43.31%
PM (TTM) 110.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSB Yearly Profit, Operating, Gross MarginsPSB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60 80 100

3

2. Health

2.1 Basic Checks

PSB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PSB has more shares outstanding
PSB has a worse debt/assets ratio than last year.
PSB Yearly Shares OutstandingPSB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
PSB Yearly Total Debt VS Total AssetsPSB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.2 Solvency

PSB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.54%
PSB Yearly LT Debt VS Equity VS FCFPSB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

PSB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.73%.
The earnings per share for PSB have been decreasing by -12.13% on average. This is quite bad
The Revenue has been growing slightly by 6.23% in the past year.
The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)-79.73%
EPS 3Y-25.28%
EPS 5Y-12.13%
EPS Q2Q%-44.55%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y1.99%
Revenue growth 5Y2.54%
Sales Q2Q%4.48%

3.2 Future

Based on estimates for the next years, PSB will show a very strong growth in Earnings Per Share. The EPS will grow by 34.79% on average per year.
PSB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.68% yearly.
EPS Next Y203%
EPS Next 2Y84.09%
EPS Next 3Y54.52%
EPS Next 5Y34.79%
Revenue Next Year13.53%
Revenue Next 2Y9.73%
Revenue Next 3Y8.81%
Revenue Next 5Y7.68%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSB Yearly Revenue VS EstimatesPSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PSB Yearly EPS VS EstimatesPSB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 246.63, which means the current valuation is very expensive for PSB.
PSB is valuated expensively when we compare the Price/Earnings ratio to 26.70, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 45.71 indicates a quite expensive valuation of PSB.
When comparing the Price/Forward Earnings ratio of PSB to the average of the S&P500 Index (22.49), we can say PSB is valued expensively.
Industry RankSector Rank
PE 246.63
Fwd PE 45.71
PSB Price Earnings VS Forward Price EarningsPSB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.76
PSB Per share dataPSB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PSB's earnings are expected to grow with 54.52% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y84.09%
EPS Next 3Y54.52%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.46%, PSB is not a good candidate for dividend investing.
With a Dividend Yield of 0.46, PSB pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.46%

5.2 History

The dividend of PSB has a limited annual growth rate of 3.39%.
PSB has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.39%
Div Incr YearsN/A
Div Non Decr YearsN/A
PSB Yearly Dividends per sharePSB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2 4 6 8

5.3 Sustainability

PSB pays out 58.46% of its income as dividend. This is a bit on the high side, but may be sustainable.
PSB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.46%
EPS Next 2Y84.09%
EPS Next 3Y54.52%
PSB Yearly Income VS Free CF VS DividendPSB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M
PSB Dividend Payout.PSB Dividend Payout, showing the Payout Ratio.PSB Dividend Payout.PayoutRetained Earnings

PS BUSINESS PARKS INC/MD

NYSE:PSB (7/19/2022, 8:09:04 PM)

After market: 187.5 +0.06 (+0.03%)

187.44

+0.06 (+0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-02 2022-05-02/amc
Earnings (Next)08-02 2022-08-02/amc
Inst Owners0.02%
Inst Owner Change0%
Ins Owners26.4%
Ins Owner Change0%
Market Cap5.18B
Analysts45
Price Target191.76 (2.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.46%
Yearly Dividend4.2
Dividend Growth(5Y)3.39%
DP58.46%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 246.63
Fwd PE 45.71
P/S 11.68
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB N/A
EV/EBITDA 17.76
EPS(TTM)0.76
EY0.41%
EPS(NY)4.1
Fwd EY2.19%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS16.05
BVpS64.42
TBVpSN/A
PEG (NY)1.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.65%
ROE 27.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 43.31%
PM (TTM) 110.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.73%
EPS 3Y-25.28%
EPS 5Y-12.13%
EPS Q2Q%-44.55%
EPS Next Y203%
EPS Next 2Y84.09%
EPS Next 3Y54.52%
EPS Next 5Y34.79%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y1.99%
Revenue growth 5Y2.54%
Sales Q2Q%4.48%
Revenue Next Year13.53%
Revenue Next 2Y9.73%
Revenue Next 3Y8.81%
Revenue Next 5Y7.68%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A